NL7308267A - - Google Patents

Info

Publication number
NL7308267A
NL7308267A NL7308267A NL7308267A NL7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A
Authority
NL
Netherlands
Application number
NL7308267A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7308267A publication Critical patent/NL7308267A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL7308267A 1972-06-15 1973-06-14 NL7308267A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
NL7308267A true NL7308267A (cg-RX-API-DMAC7.html) 1973-12-18

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7308267A NL7308267A (cg-RX-API-DMAC7.html) 1972-06-15 1973-06-14

Country Status (9)

Country Link
BE (1) BE800899R (cg-RX-API-DMAC7.html)
CA (1) CA1040619A (cg-RX-API-DMAC7.html)
DE (1) DE2330342A1 (cg-RX-API-DMAC7.html)
DK (1) DK136157B (cg-RX-API-DMAC7.html)
FR (1) FR2189034B2 (cg-RX-API-DMAC7.html)
GB (1) GB1434919A (cg-RX-API-DMAC7.html)
LU (1) LU67790A1 (cg-RX-API-DMAC7.html)
NL (1) NL7308267A (cg-RX-API-DMAC7.html)
ZA (1) ZA734037B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202100509T1 (it) 2013-04-17 2021-11-12 Sage Therapeutics Inc Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CA2918735C (en) 2013-07-19 2023-08-01 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN105579043B (zh) 2013-08-23 2021-09-14 萨奇治疗股份有限公司 神经活性类固醇、组合物和其用途
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
MY190408A (en) 2014-10-16 2022-04-21 Sage Therapeutics Inc Compositions and methods for treating cns disorders
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
LT3250210T (lt) 2015-01-26 2021-04-12 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti gydyti cns sutrikimus
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
WO2018013613A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
CA3030420C (en) 2016-07-11 2025-11-18 Sage Therapeutics, Inc. C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE
JP7670626B2 (ja) 2019-05-31 2025-04-30 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド及びその組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
CH616691A5 (en) * 1970-12-17 1980-04-15 Glaxo Lab Ltd Process for the preparation of steroid compounds and their use.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof

Also Published As

Publication number Publication date
CA1040619A (en) 1978-10-17
ZA734037B (en) 1974-05-29
DK136157C (cg-RX-API-DMAC7.html) 1978-01-23
LU67790A1 (cg-RX-API-DMAC7.html) 1973-08-16
BE800899R (fr) 1973-12-14
FR2189034A2 (cg-RX-API-DMAC7.html) 1974-01-25
AU5693773A (en) 1974-12-19
DE2330342A1 (de) 1974-01-17
GB1434919A (en) 1976-05-12
FR2189034B2 (cg-RX-API-DMAC7.html) 1977-01-21
DK136157B (da) 1977-08-22

Similar Documents

Publication Publication Date Title
FR2189034A2 (cg-RX-API-DMAC7.html)
CS158170B2 (cg-RX-API-DMAC7.html)
FR2183847B1 (cg-RX-API-DMAC7.html)
FR2206516A1 (cg-RX-API-DMAC7.html)
JPS5233060B2 (cg-RX-API-DMAC7.html)
JPS4920879U (cg-RX-API-DMAC7.html)
JPS4962711A (cg-RX-API-DMAC7.html)
CS161039B1 (cg-RX-API-DMAC7.html)
JPS4932170U (cg-RX-API-DMAC7.html)
JPS5250659Y2 (cg-RX-API-DMAC7.html)
CS156890B1 (cg-RX-API-DMAC7.html)
CS151840B1 (cg-RX-API-DMAC7.html)
JPS4913613U (cg-RX-API-DMAC7.html)
JPS4991751U (cg-RX-API-DMAC7.html)
CS159522B1 (cg-RX-API-DMAC7.html)
CS156971B1 (cg-RX-API-DMAC7.html)
CS161013B1 (cg-RX-API-DMAC7.html)
CS157934B1 (cg-RX-API-DMAC7.html)
CH590341A5 (cg-RX-API-DMAC7.html)
CH568085A5 (cg-RX-API-DMAC7.html)
BG17866A1 (cg-RX-API-DMAC7.html)
CH578862A5 (cg-RX-API-DMAC7.html)
CH585385A5 (cg-RX-API-DMAC7.html)
CH562747A5 (cg-RX-API-DMAC7.html)
BG17922A1 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
BV The patent application has lapsed